RevCAR-expressing immune effector cells for targeting of Fn14-positive glioblastoma.
Saleh HA, Mitwasi N, R Loureiro L, Kegler A, Soto KEG, Hoffmann L, Crespo E, Arndt C, Bergmann R, Bachmann M, Feldmann A.
Saleh HA, et al. Among authors: bachmann m.
Cancer Gene Ther. 2024 Apr 6. doi: 10.1038/s41417-024-00766-8. Online ahead of print.
Cancer Gene Ther. 2024.
PMID: 38582787